John P. Bilbrey - Feb 14, 2022 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Role
Director
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Stock symbol
CL
Transactions as of
Feb 14, 2022
Transactions value $
-$58
Form type
4
Date filed
2/15/2022, 04:29 PM
Previous filing
Feb 2, 2022
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $387K +5.39K +25.21% $71.76 26.8K Feb 14, 2022 Direct F1
transaction CL Common Stock Sale -$387K -4.92K -18.37% $78.66 21.8K Feb 14, 2022 Direct F2, F3
holding CL Common Stock 4.72K Feb 14, 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -5.39K -100% $0.00* 0 Feb 14, 2022 Common Stock 5.39K $71.76 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
F2 Sale of shares with proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $78.660 to $78.665, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Option became exercisable in one-third increments beginning on the first anniversary of the May 9, 2016 grant date.